简体中文 | 繁體中文 | English

Press Releases

2018-07-24 18:28 STATS Taps Dr. Helen Sun, Former CTO of JPMorgan Chase Commercial Banking Division, to Lead STATS’ Technology Operations
2018-07-24 17:52 OAG Partners with Plug and Play to Help Travel Startups Grow, Innovate and Disrupt
2018-07-24 17:50 RDC Announces New CEO Tom Walsh
2018-07-24 17:48 Toshiba Memory Corporation Unveils Industry's First SSDs Utilizing 96-Layer, 3D Flash Memory
2018-07-24 13:00 Gemalto Helps Companies Gain Valuable Data Insights, Reduce Cost and Time with Automatic Software Updates
2018-07-24 10:00 FDA Clears First Nanotechnology Peek Devices for Spinal Intervertebral Fusion
2018-07-24 09:49 Darigold Expands Global Operations
2018-07-23 19:07 Ferring’s Heat-Stable Carbetocin Could Save Thousands of Women’s Lives by Preventing Excessive Bleeding after Childbirth
2018-07-23 17:45 AURAK Enters into a Memorandum of Understanding with Al-Farabi Kazakh National University
2018-07-23 12:12 RFG Brands Continue Down Silk Road into Asian Market
2018-07-23 09:38 GlobalPlatform Expands Annual Seminar in China
2018-07-23 09:35 Philip Morris International Announces Non-Executive Board Chairman Louis Camilleri to Assume CEO Role at Ferrari S.p.A.
2018-07-20 18:22 Toshiba Memory Corporation Develops 96-layer BiCS FLASH™ with QLC Technology
2018-07-20 18:20 FlipNpik Opens Its Private Sale to Public and Introduces Fiat-Based Payment Gateway
2018-07-20 16:09 Cushman & Wakefield Acquires Inc RE Australia
2018-07-20 15:00 UAE’s $8 Billion Tech Industry Presents Extensive Growth Opportunities for Chinese Businesses
2018-07-20 13:10 The Poseidon Foundation: Liverpool Bids to Be First ‘Climate Positive’ City by End of 2020
2018-07-20 13:05 Emmaus Life Sciences Announces the New England Journal of Medicine has Published the Phase 3 Trial Results of Endari™ (L-Glutamine Oral Powder) in Sickle Cell Disease
2018-07-20 09:20 Seoul Semiconductor Delivers Its Innovative LED "SunLike" to U.S. Lighting Market
2018-07-20 09:16 Boehringer Ingelheim and Lilly announce Trajenta®’s CARMELINA® cardiovascular outcome trial met its primary endpoint